Carotid Artery Intima–Media Thickness Predicts Major Cardiovascular Events During 7-Year Follow-Up in 64-Year-Old Women Irrespective of Other Glucometabolic Factors
Restricted accessResearch articleFirst published online July, 2017
Carotid Artery Intima–Media Thickness Predicts Major Cardiovascular Events During 7-Year Follow-Up in 64-Year-Old Women Irrespective of Other Glucometabolic Factors
Cardiovascular (CV) disease (CVD) is a leading cause of morbidity and mortality worldwide. Most CV events are caused by atherosclerosis. Diabetes and impaired glucose tolerance are associated with greater carotid intima–media thickness (IMT) and increased risk for CVD. The present study examined if common carotid artery IMT (CCAIMT) is predictive of CVD irrespective of glucose tolerance category and glycated hemoglobin (HbA1c) in a sample of 639 women with different glucose tolerance categories. During 7-year follow-up, 30 events in the cardiac and 32 events in the cerebral territory were documented. Unadjusted Cox hazard models showed that CCAIMT, glucose tolerance category, and HbA1c were associated with increased risk. An adjusted and extended model, including CCAIMT, glucose tolerance category, and HbA1c, showed that CCAIMT was still associated with events with an almost unchanged hazard ratio. In conclusion, this study suggests that CCAIMT is predictive of major CV events during 7-year follow-up, irrespective of glucose tolerance category, HbA1c, and other established risk factors in a cohort of 64-year-old women.
AlwanAArmstrongTBettcherD. Global status report on non-communicable diseases 2010. Geneva, Switzerland: World Health Organization; 2011.
2.
LibbyPRidkerPMMaseriA. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–1143.
3.
SteinJHKorcarzCEHurstRT. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. J Am Soc Echocardiography. 2008;21(2):376–376.
4.
LorenzMWMarkusHSBotsMLRosvallMSitzerM. Prediction of clinical cardiovascular events with carotid intima-media thickness. A systematic review and meta-analysis. Circulation. 2007;115(4):459–467.
5.
O’LearyDHPolakJF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002;90(10c):18L–21L.
6.
EbrahimSPapacostaOWhincupP. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999;30(4):841–850.
7.
BonoraETessariRMiccioloR. Intimal-medial thickness of the carotid artery in non-diabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care. 1997;20(4):627–631.
8.
WagenknechtLEDÁgostinoRBJrHaffnerSMSavagePJRewersM. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1998;21(11):1812–1818.
9.
GuvenerNTutuncuNBOtoAErbasT. Major determinants of the carotid intima-media thickness in type 2 diabetic patients: age and body mass index. Endocr J. 2000;47(5):525–533.
10.
SigurdardottirVFagerbergBHultheJ. Preclinical atherosclerosis and inflammation in 61-year-old men with newly diagnosed diabetes and established diabetes. Diabetes Care. 2004;27(4):880–884.
11.
Temelkova-KurktschievTSKoehlerCLeonhardtW. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care. 1999;22(2):333–338.
12.
HenryRMKostensePJDekkerJM. Carotid artery remodeling: a maladaptive phenomenon in type 2 diabetes but not impaired glucose metabolism: the Hoorn study. Stroke. 2004;35(3):671–676.
13.
HuntKJWilliamsKRiveraD. Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol. 2003;23(10):1845–1850.
14.
MooradianAD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150–159.
15.
TominagaMIgarashiKEguchiHKatoTManakaHSekikawaA. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 1999;22(6):920–924.
16.
The DECODE Study Group, on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet. 1999;344(9179):1343–1350.
17.
Emerging Risk Factors Collaboration; SarwarNGaoPSeshasaiSR. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222.
18.
AnandSSDagenaisGRMohanV; on behalf of the EpiDREAM Investigators. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Prev Cardiol. 2011;19(4):755–764.
19.
PithaJAuzkýOKovárJ. Changes in cardiovascular risk profile in women after menopause (Prague Pre and Post Menopausal female study). Cor Et Vasa. 2014;56(2):e113–e117.
20.
BeckmanJACreagerMALibbyP. Diabetes and atherosclerosis. Epidemiology, pathophysiology and management. JAMA. 2002;287(19):2570–2581.
21.
LarsenJRBrekkeMBergengenL. Mean HbA1c over 18 years predicts carotid intima-media thickness in women with type 1 diabetes. Diabetologia. 2005;48(4):776–779.
22.
RiveraJJChoiEKYoonYE. Association between increasing levels of hemoglobin A1c and coronary atherosclerosis in asymptomatic individuals without diabetes mellitus. Coron Artery Dis. 2010;21(3):157–163.
23.
EegOlofssonKCederholmJNilssonP. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med. 2010;268(5):471–482.
24.
BrohallGBehreCJHultheJWikstrandJFagerbergB. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care. 2006;29(2):363–367.
25.
Englund ÖggeLBrohallGBehreCJSchmidtCFagerbergB. Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care. 2006;29(4):908–913.
26.
WallenfeldtKBokemarkLWikstrandJHultheJFagerbergB. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke. 2004;35(10):2248–2252.
27.
PrahlUWikstrandJBergströmGMBehreCJHultheJFagerbergB. Slightly elevated high-sensitivity C-reactive protein (hsCRP) concentrations are associated with carotid atherosclerosis in women with varying degrees of glucose tolerance. Angiology. 2010;61(8):793–801.
28.
WendelhagILiangQGustavssonTWikstrandJ. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurements of intima-media thickness. Stroke. 1997;28(11):2195–2200.
29.
LudvigssonJFAnderssonEEkbomA. External review and validation of the Swedish national inpatient register. BMC Public Health. 2001;11:450–455.
30.
LorenzMWPolakJFKavousiM; on behalf of the PROG-IMT Study Group. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet. 2012;379(9831):2053–2062.
31.
LorenzMWPriceJFRobertsonC. Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT Collaboration. Diabetes Care. 2015;38(10):1921–1929.
32.
DeoRKKarkiPSharmaSKAchatyaP. Association of cardiovascular events with glycosylated haemoglobin in diabetic patients. Katmandu Univ Med J. 2008;6(24):476–485.
33.
ArbelYZlotnikMHalkinA. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol. 2014;103(3):223–227.
34.
AvogaroAAlbieroMMenegazzoLde KreutzenbergSFadiniGP. Endothelial dysfunction in diabetes. The role of reparatory mechanisms. Diabetes Care. 2011;34(suppl 2):S285–S290.
35.
AltinCSadeLEGezmisE. Assessment of subclinical atherosclerosis by carotid intima-media thickness and epicardial adipose tissue thickness in prediabetes [published online April 10, 2016]. Angiology. pii:0003319716643669.
36.
SirbuANicolaeHMartinS. IGF-I and insulin resistance are major determinants of common carotid artery thickness in morbidly obese young patients. Angiology. 2016;67(3):259–265.
37.
CalannaSScicaliRDi PinoA. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes. Nutr Metab Cardiovasc Dis. 2014;24(6):670–676.
38.
van den OordSCSijbrandsEJten KateGL. Carotid intima-media thickness for cardiovascular risk assessment: systematic review and meta-analysis. Atherosclerosis. 2013;228(1):1–11.
39.
de KoningLMerchantATPougeJAnandSS. Waist circumference and waist to hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28(7):850–856.
40.
ZhangCRexrodeKMvan DamRMLiTYHuFB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Sixteen years of follow-up in US women. Circulation. 2008;117(13):1658–1667.
41.
GelberRPGazianoJMOravEJMansonJEBuringJEKurthT. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol. 2008;52(8):605–615.
42.
MillerM. Dyslipidemia and cardiovascular risk: the importance of early prevention. QJ Med. 2009;102(9):657–667.
43.
TothPPBarterPJRosensonRS. High-density lipoproteins: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7(5):484–525.
44.
GoffDCLloyd-JonesDMBennettG; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S49–S73.
45.
NordestgaardBGBennMSchnohrPTybjaerg-HansenA. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299–308.
46.
FreibergJJTybjaerg-HansenAJensenJSNordestgaardBG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 2008;300(18):2142–2152.
47.
TriantafyllidiHPavlidisGTrivilouP. The association of elevated HDL levels with carotid atherosclerosis in middle-aged women with untreated essential hypertension. Angiology. 2015;66(10):904–910.
48.
BrunnerHCockcroftJRDeanfieldJ; Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and diseases. A statement by the working group on endothelins and endothelial factors of the European society of hypertension. J Hypertens. 2005;23(2):233–246.
49.
BurnDM. Epidemiology of smoking-induced cardiovascular disease. Progr Cardiovasc Dis. 2003;46(1):11–29.
50.
OnutRBalanescuSConstantinescuDCalmacLMarinescuMDorobantuM. Imaging atherosclerosis by carotid intima-media thickness in vivo: how to, where and in whom?Maedica (Buchar). 2012;7(2):153–162.
51.
BauerMCaviezelSTeynorAErbelRMahabadiAASchmidt-TrucksässA. Carotid intima-media thickness as a biomarker of subclinical atherosclerosis. Swiss Med Wkly. 2012;142:w13705.
52.
ChamblessLEHeissGFolsomAR. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol. 1997;146(6):483–494.
53.
JeevarethinamAVenurajuSWeymouthMAtwalSLahiriA. Carotid intimal thickness and plaque predict prevalence and severity of coronary atherosclerosis: a pilot study. Angiology. 2015;66(1):65–69.
54.
NambiVChamblessLHeMFolsomARMosleyTBoerwinkleE. Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study. Eur Heart J. 2012;33(2):183–190.
